FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)

View source ↗

Summary

The FDA approved a supplemental application for Baraclude (entecavir) by E.R. Squibb & Sons, L.L.C. This action updates the labeling for chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Baraclude (entecavir)

Snippet

SUPPL AP for BARACLUDE (ENTECAVIR)